Monoclonal antibodies (mAbs) allow disease targets to be attacked with high precision and have been developed to treat an array of diseases. Producers of mAbs, equipped with USP's standards, best practices, education, and technical assistance, are accelerating their R&D to drive the next generation of targeted medical treatments.
Explore USP's portfolio of mAb solutions
mAb Analytical Guide
This interactive tool features resources for the assessment of mAb quality and safety. It includes reference standards, documentary standards, educational content, and more.
Products & Resources
Related Products
Below is a current list of mAb-related USP official standards published in the United States Pharmacopeia-National Formulary (USP-NF), with related USP Reference Standards or ARMs. Included in the table below are some of the monographs and general chapters currently under development or in revision (labeled with an *).
Click here
Product Information
- mAb Reference Standards Flyer (English, Spanish, Chinese, Portuguese)
- mAb Analytical Guide / (mAb Analytical Guide Flyer)
- Infographic: Ensuring quality in monoclonal antibody therapeutics with USP Standards
- Development of New USP Reference Standards: Characterization of Three Monoclonal Antibodies Using High Resolution Mass Spectrometry
- Antibody-drug Conjugate (ADC) Standards & Materials
Click here
Excipient Standards Used in Manufacturing
- USP offers the following reference standards for excipients used in the mAb manufacturing process or present in mAb formulations. Pharmaceutical excipients are substances other than the active pharmaceutical ingredient (API) that have been appropriately evaluated for safety and are intentionally included in a drug delivery system.
Click here
Formulation and Packaging Standards
Click here
Injectables-related USP-NF Documentary Standards
Provided below are the USP Documentary Standards related to therapies administered either subcutaneously or by intravenous infusion published in the United States Pharmacopeia-National Formulary (USP–NF).
Click here
Education
- What are Monoclonal Antibodies [mAb]? | John F. Kokai-Kun, PhD
- mAb Attribute Information
- Overview of USP General Chapter <129> Analytical Procedures of Recombinant Therapeutic Monoclonal Antibodies
- Glycosylation
- USP Reference Standard Monoclonal Antibodies: Tools to Verify Glycan Structure
- More Comprehensive Standards for Monitoring Glycosylation
- Measurement of macro- and micro-heterogeneity of glycosylation in biopharmaceuticals: a pharmacopeia perspective
- Characterization of USP mAbs as a Tool for Verification of Macro- and Micro-Heterogeneity of Glycosylation in mAbs and Other Biotherapeutics
- Aggregation
- Charge variant
- Higher order structure (HOS)
- Biopharmaceutical continuous manufacturing
- Impurity testing
- Residual DNA
- Host cell proteins (HCPs)
- The Role of Public Standards in the Development of Biosimilars
- New USP Standards for Characterization of Therapeutic Proteins | Quality Matters | U.S. Pharmacopeia Blog
- Multi-Attribute Method (MAM)
Click here
Sign up for updates